IS8371A - Notkun breyttra sýklósporína til að meðhöndla HCVsjúkdóma - Google Patents

Notkun breyttra sýklósporína til að meðhöndla HCVsjúkdóma

Info

Publication number
IS8371A
IS8371A IS8371A IS8371A IS8371A IS 8371 A IS8371 A IS 8371A IS 8371 A IS8371 A IS 8371A IS 8371 A IS8371 A IS 8371A IS 8371 A IS8371 A IS 8371A
Authority
IS
Iceland
Prior art keywords
treat hcv
disorders
cyclosporins
modified
modified cyclosporins
Prior art date
Application number
IS8371A
Other languages
English (en)
Other versions
IS2917B (is
Inventor
Kan-yuchi Ikenouchicho Fukakusa Fushimi-ku Makoto Hijikata
Nishibugyo-Cho Fushimi-Ku Kunitada Shimotohno
Nishinotoin-nishiiru Ichijodori Kamigyo-ku Koichi Watashi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8371A publication Critical patent/IS8371A/is
Publication of IS2917B publication Critical patent/IS2917B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IS8371A 2003-09-03 2006-03-24 Notkun breyttra sýklósporína til að meðhöndla HCV kvilla IS2917B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320638.0A GB0320638D0 (en) 2003-09-03 2003-09-03 Organic compounds
PCT/EP2004/009804 WO2005021028A1 (en) 2003-09-03 2004-09-02 Use of modified cyclosporins for the treatment of hcv disorders

Publications (2)

Publication Number Publication Date
IS8371A true IS8371A (is) 2006-03-24
IS2917B IS2917B (is) 2014-12-15

Family

ID=28686843

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8371A IS2917B (is) 2003-09-03 2006-03-24 Notkun breyttra sýklósporína til að meðhöndla HCV kvilla

Country Status (29)

Country Link
US (1) US7968518B2 (is)
EP (2) EP1797892B1 (is)
JP (1) JP4688806B2 (is)
KR (1) KR101116968B1 (is)
CN (1) CN1842343A (is)
AU (2) AU2004268382A1 (is)
BR (1) BRPI0414062B8 (is)
CA (1) CA2537137C (is)
CY (1) CY1110506T1 (is)
DE (1) DE602004022061D1 (is)
DK (1) DK1663287T3 (is)
ES (1) ES2328361T3 (is)
GB (1) GB0320638D0 (is)
HR (1) HRP20090535T1 (is)
IL (1) IL173909A (is)
IS (1) IS2917B (is)
MA (1) MA28032A1 (is)
MX (1) MXPA06002394A (is)
NO (1) NO20061479L (is)
NZ (1) NZ545495A (is)
PL (1) PL1663287T3 (is)
PT (1) PT1663287E (is)
RU (1) RU2389501C2 (is)
SG (1) SG149063A1 (is)
SI (1) SI1663287T1 (is)
TN (1) TNSN06071A1 (is)
TW (1) TWI342782B (is)
WO (1) WO2005021028A1 (is)
ZA (1) ZA200601550B (is)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69928938T2 (de) 1998-07-01 2006-08-17 Debiopharm S.A. Neues cyclosporin mit verbesserter wirkung
WO2004082629A2 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
GB0500020D0 (en) * 2005-01-04 2005-02-09 Novartis Ag Organic compounds
RU2394589C2 (ru) * 2004-07-14 2010-07-20 Новартис Аг Применение комбинации циклоспорина и пэгилированного интерферона для лечения гепатита с (hcv)
EP1809656A4 (en) 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
EP1804823A4 (en) 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
SG139750A1 (en) * 2004-10-01 2008-02-29 Debiopharm Sa Ch Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3- [etval]4-cyclosporin
JP5139065B2 (ja) * 2004-10-01 2013-02-06 スシネキス インク Ｃ型肝炎感染の治療及び予防のための３−エーテル及び３−チオエーテル置換シクロスポリン誘導体
US7196161B2 (en) 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
ATE412005T1 (de) 2004-11-22 2008-11-15 Astellas Pharma Inc Zyklosporinanalog
KR20070089954A (ko) * 2004-12-23 2007-09-04 노파르티스 아게 플라비비리대 치료용 화합물
BRPI0519345A2 (pt) 2004-12-23 2009-01-20 Novartis Ag composiÇço para tratamento do hcv
AR054778A1 (es) * 2005-06-17 2007-07-18 Novartis Ag Uso de sangliferina en hcv
CN101316606B (zh) * 2005-09-30 2015-05-27 西尼克斯公司 治疗和预防丙型肝炎感染的方法和药物组合物
CN105169369B (zh) * 2005-09-30 2019-10-18 中美华世通生物医药科技（武汉）有限公司 治疗和预防丙型肝炎感染的方法和药物组合物
WO2007041631A1 (en) 2005-09-30 2007-04-12 Scynexis, Inc. ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION
JP5218051B2 (ja) * 2005-10-26 2013-06-26 アステラス製薬株式会社 新規環状ペプチド化合物
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
ATE502633T1 (de) 2006-05-19 2011-04-15 Scynexis Inc Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
KR101089112B1 (ko) * 2006-06-02 2011-12-06 피씨 제스띠옹 에스.아.에스. 활성 전자 관리
AU2007306316B2 (en) * 2006-10-12 2011-10-27 Kyushu University Use of modified cyclosporins
WO2008069917A2 (en) * 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
CN105056207A (zh) * 2007-01-04 2015-11-18 德比奥法姆国际股份有限公司 用于治疗Ullrich先天性肌营养不良的非免疫抑制性环孢霉素
CN101687012A (zh) * 2007-05-02 2010-03-31 安斯泰来制药有限公司 新的环肽化合物
US20110158908A1 (en) * 2007-08-24 2011-06-30 Sapporo Medical University Cyclosporin a-binding protein
CN102083852A (zh) * 2008-06-06 2011-06-01 西尼克斯公司 环孢菌素类似物及其在治疗hcv感染中的应用
US20090306033A1 (en) * 2008-06-06 2009-12-10 Keqiang Li Novel cyclic peptides
KR20110045032A (ko) * 2008-07-30 2011-05-03 이소테크니카 파마 인크. 비면역억제성 사이클로스포린 유사체 분자
MX2011003259A (es) * 2008-09-24 2011-04-21 Astellas Pharma Inc Compuesto de peptido y metodo para producir el mismo.
BRPI0920502A2 (pt) * 2008-11-06 2015-12-22 Debio Rech Pharma Sa compostos cicloundecadepsipeptídeos e seu uso como medicamento
EP2376524B1 (en) * 2008-12-31 2017-03-15 Cypralis Limited Derivatives of cyclosporin a
RU2492181C2 (ru) 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
WO2011063076A1 (en) 2009-11-19 2011-05-26 Itherx Pharmaceuticals, Inc. Methods of treating hepatitis c virus with oxoacetamide compounds
JP2013513595A (ja) 2009-12-09 2013-04-22 サイネクシス，インコーポレーテッド 新規環状ペプチド
US8623814B2 (en) 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
CN103179974A (zh) 2010-10-05 2013-06-26 诺华有限公司 丙型肝炎病毒感染的新疗法
AU2011334984A1 (en) 2010-11-30 2013-07-04 Novartis Ag New treatments of Hepatitis C virus infection
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9200038B2 (en) 2010-12-15 2015-12-01 Ciclofilin Pharmaceuticals Corp. Cyclosporine analogue molecules modified at amino acid 1 and 3
EP2691094A1 (en) 2011-03-31 2014-02-05 Novartis AG Alisporivir to treat hepatitis c virus infection
BR112013024809A2 (pt) 2011-04-01 2016-09-06 Novartis Ag tratamento para infecção com vírus de hepatite b sozinho ou em combinação com vírus de hepatite delta e doenças do fígado associadas
MA35029B1 (fr) 2011-04-13 2014-04-03 Novartis Ag Traitement de l'infection par le virus de l'hépatite c avec l'alisporivir
RU2014116988A (ru) 2011-09-27 2015-11-10 Новартис Аг Алиспоривир для лечения инфекции, вызванной вирусом гепатита с
US20150133369A1 (en) 2012-05-07 2015-05-14 Steven Kovacs Pharmacokinetic modulation with alisporivir
AU2013267435B2 (en) 2012-06-01 2017-11-09 Allergan, Inc. Cyclosporin A analogs
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
WO2015008223A1 (en) 2013-07-17 2015-01-22 Novartis Ag Treatment of hepatitis c virus infection with alisporivir and ribavirin
AU2014311346A1 (en) 2013-08-26 2016-03-17 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C
WO2015136455A1 (en) 2014-03-13 2015-09-17 Novartis Ag New treatments of hepatitis c virus infection
WO2016073480A1 (en) 2014-11-03 2016-05-12 Enanta Pharmaceuticals, Inc. Novel cyclosporin analogues for preventing or treating hepatitis c infection
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
US20230330132A1 (en) * 2020-08-24 2023-10-19 Nanomerics Limited Viral inhibitors

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4917888A (en) 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
JP2514950B2 (ja) 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質，その製造法および中間体
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
SK278808B6 (sk) * 1990-11-02 1998-03-04 Novartis Ag Cyklosporíny, ich použitie pri príprave liečiva na
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US6174868B1 (en) * 1992-09-10 2001-01-16 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of hepatitis C virus-associated diseases
DE69321823T2 (de) 1992-10-21 1999-06-02 Taito Co., Ltd., Tokio/Tokyo 2-amino-1, 3- propandiolverbindung und immunosuppressium
WO1995013090A1 (en) 1993-11-10 1995-05-18 Enzon, Inc. Improved interferon polymer conjugates
JP3870419B2 (ja) 1994-08-22 2007-01-17 三菱ウェルファーマ株式会社 ベンゼン化合物およびその医薬としての用途
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
JP3786447B2 (ja) * 1995-03-31 2006-06-14 エーザイ株式会社 Ｃ型肝炎の予防・治療剤
US5908621A (en) 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
FR2757522B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757520B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
FR2757521B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
DK1319651T3 (da) 1997-04-04 2005-08-01 Mitsubishi Pharma Corp 2-aminopropan-1,3-diolforbindelser, medicinsk anvendelse deraf og mellemprodukter til syntese af disse
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
DE69928938T2 (de) 1998-07-01 2006-08-17 Debiopharm S.A. Neues cyclosporin mit verbesserter wirkung
PL359411A1 (en) 2000-07-13 2004-08-23 Sankyo Company, Limited Amino alcohol derivatives
EP1315735A4 (en) 2000-08-31 2005-04-06 Merck & Co Inc Phosphate derivatives as immunoregulatory compounds
WO2002032447A2 (en) * 2000-10-19 2002-04-25 Fujisawa Pharmaceutical Co., Ltd. Cell damage inhibitor
JP2002125683A (ja) * 2000-10-27 2002-05-08 Tokyoto Igaku Kenkyu Kiko インターフェロンの有効性を予測する方法並びにそれに用いられるプライマー及びプローブ
SK11942003A3 (sk) 2001-03-26 2004-03-02 Novartis Ag Deriváty 2-aminopropanolu, ich použitie a farmaceutická kompozícia, ktorá ich obsahuje
JP2002316985A (ja) 2001-04-20 2002-10-31 Sankyo Co Ltd ベンゾチオフェン誘導体
US6960692B2 (en) 2001-09-27 2005-11-01 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
DE60235900D1 (de) 2001-09-27 2010-05-20 Kyorin Seiyaku Kk Osuppressivum
EP1575964B1 (en) 2002-01-18 2009-11-11 Merck & Co., Inc. N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
US7479504B2 (en) 2002-01-18 2009-01-20 Merck & Co., Inc. Edg receptor agonists
US20030213603A1 (en) 2002-05-14 2003-11-20 Fisher David B. Dual use extension apparatus for a tool
CA2489552A1 (en) 2002-06-28 2004-01-08 Idenix (Cayman) Limited 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
GB0313444D0 (en) 2003-06-11 2003-07-16 Midland Medical Technologies L Modular dysplasia cup
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
SG139750A1 (en) 2004-10-01 2008-02-29 Debiopharm Sa Ch Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3- [etval]4-cyclosporin
BRPI0519345A2 (pt) 2004-12-23 2009-01-20 Novartis Ag composiÇço para tratamento do hcv

Also Published As

Publication number Publication date
DK1663287T3 (da) 2009-11-09
MA28032A1 (fr) 2006-07-03
HK1091732A1 (en) 2007-01-26
ZA200601550B (en) 2007-05-30
WO2005021028A1 (en) 2005-03-10
PT1663287E (pt) 2009-09-03
MXPA06002394A (es) 2006-06-20
EP1663287A1 (en) 2006-06-07
HRP20090535T1 (hr) 2009-11-30
NZ545495A (en) 2010-01-29
DE602004022061D1 (de) 2009-08-27
IS2917B (is) 2014-12-15
EP1797892A1 (en) 2007-06-20
AU2008203031A1 (en) 2008-07-31
GB0320638D0 (en) 2003-10-01
AU2004268382A1 (en) 2005-03-10
KR101116968B1 (ko) 2012-03-14
JP2007504260A (ja) 2007-03-01
PL1663287T3 (pl) 2009-12-31
IL173909A0 (en) 2006-07-05
US7968518B2 (en) 2011-06-28
AU2008203031B2 (en) 2011-04-07
CY1110506T1 (el) 2015-04-29
BRPI0414062B1 (pt) 2019-06-25
ES2328361T3 (es) 2009-11-12
KR20060132798A (ko) 2006-12-22
TNSN06071A1 (en) 2007-10-03
BRPI0414062A (pt) 2006-10-24
RU2389501C2 (ru) 2010-05-20
SG149063A1 (en) 2009-01-29
CA2537137A1 (en) 2005-03-10
RU2006110533A (ru) 2007-10-10
TW200524626A (en) 2005-08-01
EP1663287B1 (en) 2009-07-15
IL173909A (en) 2011-03-31
US20070275884A1 (en) 2007-11-29
NO20061479L (no) 2006-06-02
SI1663287T1 (sl) 2009-10-31
CN1842343A (zh) 2006-10-04
CA2537137C (en) 2013-05-28
TWI342782B (en) 2011-06-01
JP4688806B2 (ja) 2011-05-25
BRPI0414062B8 (pt) 2021-05-25
EP1797892B1 (en) 2013-10-23

Similar Documents

Publication Publication Date Title
IS8371A (is) Notkun breyttra sýklósporína til að meðhöndla HCVsjúkdóma
IS8913A (is) Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk
IS8023A (is) Samsett meðferð til að meðhöndla ónæmisbólgusjúkdóma
CY2016035I1 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
DK1485127T3 (da) Anvendelse af midler til behandling af inflammation
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1673104T4 (da) Fremføring af terapeutiske forbindelser til hjernen og andre væv
DK1706112T3 (da) Fremgangsmåder til at behandle en inflammatorisk-beslægtet sygdom
DK1687066T3 (da) Fremgangsmåder til immunmodulering
EP1965827A4 (en) TREATMENT OF CONDITIONS RELATED TO DEMYELINATION
IS7851A (is) 1-asýl-pýrrólídínafleiður til að meðhöndla veirusýkingar
IS8321A (is) Stöðug afbrigði tegaseródvetnismaleats
IS8094A (is) Notkun 10-hýdroxý-10,11-díhýdrókarbamasepínafleiða til að meðhöndla geðbrigðasýki
DE602004004262D1 (de) Ultraschallbehandlung von gewebematrices
DE60326190D1 (de) des Körpers
ATE369136T1 (de) Therapeutische behandlung
DE602004000627D1 (de) Hautreinigungsmittel
DE602004024651D1 (de) Verbesserungen von dampfinjektoren
ATE395899T1 (de) Haarbehandlungszusammensetzungen
DE60305300D1 (de) Haarbehandlungszusammensetzungen
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DK1351697T3 (da) Lægemiddel til fremme af regenerationen af væv
DE602004011679D1 (de) Behandelung von Störungen
ATE482707T1 (de) 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen
ATE446757T1 (de) 1-ä2h-1-benzopyran-2-one-8-ylü- piperazinderivative zur behandlung von bewegungsstörungen